Everyday People Matter
Patients suffering from Chronic Obstructive Pulmonary Disease (“COPD”), a serious respiratory condition, have been struggling to access necessary medical attention during the COVID-19 pandemic. The Covid-19 pandemic has helped shine the spotlight on respiratory...
The Food & Drug Administration (FDA) has approved a new treatment for the respiratory condition called Chronic Obstructive Pulmonary Disease (COPD). According to the FDA, patients who suffer from this often deadly ailment now have a new tool with which to treat symptoms. The medication is delivered via inhaler, with a spray called Striverdi Respimat and the active ingredient known…
Sufferers of COPD (Chronic Obstructive Pulmonary Disease) seek to promote awareness of this chronic respiratory condition during the month of November. COPD encompasses bronchitis, emphysema, and other lung diseases. Symptoms include chronic cough, shortness of breath and fatigue. COPD is characterized as obstructed airway through the lungs. This inflammation usually will worsen over time. COPD is also the third leading…